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Abstract
Background: Remote precoditioning of trauma (RPCT) confers cardioprotective effects against myo-
cardial ischemia/reperfusion injury, which are mediated by spinal opioid receptors. The aim of this 
study was to identify the roles of opioid receptor subtypes in the cardioprotective effect of RPCT and 
possible mechanisms.
Methods: In this study, 192 Sprague-Dawley rats were allocated to 12 groups. Except for the sham 
group, rats in all groups were subjected to myocardial ischemia reperfusion. Rats in the ischemia pre-
condition (IPC) group were treated with IPC. In the RPCT groups, an abdominal incision was made 
15 min before inducing ischemia. The selective delta-, kappa-, and mu-opioid receptor antagonists were 
administered to groups of animals receiving RPCT, respectively. Data were collected for myocardial 
infarct size, intercellular adhesion molecule 1 (ICAM-1), plasma cardiac troponin I (cTnI) concentra-
tions, activation of protein kinase C epsilon (PKCe) in myocardial cell membranes, and adenosine 
release in the spinal cord.
Results: Compared with the control groups, infarct size, plasma concentrations of cTnI, and myocar-
dial ICAM-1 expression were significantly lower, while adenosine release and PKCe activation were 
enhanced in the IPC and RPCT groups. Compared with the RPCT group, infarct size, plasma cTnI 
concentration, and myocardial ICAM-1 expression were greater and adenosine release and PKCe acti-
vation were reduced in the mu-opioid receptor antagonist plus RPCT group.
Conclusions: The spinal mu-opioid receptor mediated the cardiac protective effect of RPCT. The 
mechanism may be enhanced by adenosine release in the spinal cord and PKCe activation in the myo-
cardium, thereby inhibiting inflammation induced by ischemia/reperfusion injury. (Cardiol J 2017; 
24, 3: 314–323)
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Introduction
In 2004, Ren et al. [1] first described the con-
cept of remote preconditioning of trauma (RPCT) in 
a mouse model. They found that the creation of an 
abdominal incision before cardiac ischemia/reperfu-
sion (IR) reduced the rate of associated myocar-
dial injury. Peripheral nociception and neurogenic 
activation of protein kinase C epsilon (PKCe) was 
found to mediate this cardioprotective effect [2].
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In a rat model of IR injury, we observed the 
cardioprotective effect of RPCT and the fact that 
opioid receptors in the spinal cord mediated this 
effect using the non-selective opioid receptor an-
tagonist — naloxone [3]. However, results from 
the peripheral mechanism of RPCT study indicated 
that endogenous opioids made no contribution to 
the cardioprotective effect of RPCT [4]. The differ-
ence between opioid receptor expression in the rat 
myocardium and spinal cord seems to be the reason 
for this phenomenon. No evidence was obtained to 
prove the expression of mu-opioid receptors in the 
rat myocardium [5].
Activation of spinal cord opioid receptors with 
morphine was found to mediate the cardioprotective 
effect of RPCT against IR injury [6]. In particular, 
activation of the mu receptor upregulated the release 
of adenosine in the spinal cord [7, 8], and this effect 
played an essential role in modulating peripheral 
inflammation [9]. We hypothesize that mu receptor-
related adenosine release in the central nervous 
system mediates the cardioprotective effect of RPCT.
This study was conducted to further investi-
gate the roles of opioid receptor subtypes in the 
mediation of the cardioprotective effect of RPCT, 
as well as the underlying mechanism in the spinal 
cord adenosine system.
Methods
The Anhui Medical University Committee 
on the Use of Live Animals in Teaching and Re-
search provided ethical approval for this study 
(Protocol number: LLSC20150041; Approval date: 
12-01-2015). Male Sprague-Dawley rats weighing 
250–300 g were provided by the Anhui Medical 
University experimental animal center. They were 
housed in separate cages with a 12-h light/dark 
cycle and given free access to food and water.
Study groups and experimental protocol
The rats were randomly assigned to the fol-
lowing 12 groups (n = 24 for control groups and 
RPCT groups; n = 18 for other groups) (Fig. 1):
1)  Sham group: intrathecal catheter place-
ment, heart exposure, and suturing with-
out ischemia/reperfusion;
2, 3)  Control groups: intrathecal administration 
of 10 μL normal saline plus induction of 
I/R. Six rats were in control group 1, and 
18 rats comprised control group 2;
4)   Ischemia preconditioning (IPC) group: 
intrathecal administration of 10 μL normal 
saline, followed by three cycles of 5 min 
ischemia and 5 min reperfusion before I/R;
Figure 1. The schematic diagram for the experiment protocol. Sham group received no occlusion or reperfusion; all 
other groups were subjected to 30 min ischemia and 120 min reperfusion. Control groups received intrathecal adminis-
tration of 10 μL normal saline plus induction of ischemia/reperfusion (IR) injury. The ischemia preconditiong (IPC) group 
received three cycles of 5 min of ischemia followed by 5 min of reperfusion before IR injury plus intrathecal normal 
saline. In the remote precoditioning of trauma (RPCT) groups, abdominal incision was made 15 min before IR injury, 
plus intrathecal normal saline. In opioid receptor antagonist + RPCT groups, 15 nM of specific opioid receptor subtype 
antagonist were administrated intrathecally followed by 10 μL normal saline flush 10 min before abdominal incision 
was made. For the opioid receptor antagonist self-control groups, the protocol was the same as for the three subtype 
opioid receptor antagonist plus remote preconditioning of trauma groups but without remote preconditioning of trauma.
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5, 6) RPCT groups: abdominal incision 15 min 
before IR injury plus intrathecal admin-
istration of 10 μL normal saline. Six rats 
were in RPCT group 1, and 18 rats com-
prised RPCT group 2;
7–9)  Opioid receptor antagonist plus RPCT 
groups: intrathecal administration of 15 nM 
selective delta (naltrindole [NTD]), kappa 
(nor-binaltorphimine [nor-BNI]), or mu 
(D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-
NH2 [CTOP]) opioid receptor antagonist 
(Sigma Aldrich, St. Louis, USA), followed 
by 10 μL normal saline flush 15 min before 
abdominal incision. The doses of these 
antagonists were selected on the basis of 
the previous study [21];
10–12) Opioid receptor antagonist self-control 
groups: same protocols as for groups 5–7, 
but without RPCT.
Intrathecal catheter placement
Catheters were inserted according to methods 
described by Yaksh and Rudy [10], and as previ-
ously described. Animals were anesthetized by 
intraperitoneal injection of pentobarbitone (80 mg/ 
/kg for control group 1 and RPCT group 1, 50 mg/kg 
for other groups). After skin sterilization, a small 
polyethylene-10 catheter (external diameter, 
0.8 mm; internal diameter, 0.4 mm; Smiths Medical 
International, Kent, UK) was inserted through 
a puncture into the atlanto-occipital membrane, then 
advanced 4 cm to the level of the thoracic spinal 
cord. The intrathecal position of the catheter was 
confirmed via backflow of cerebrospinal fluid. After 
insertion, wounds were closed and the animals 
returned to their cages. Subsequently, the rats 
were monitored for 3 days. Thirty-one animals 
developed motor or sensory deficits during this 
period and were excluded from the study.
Ischemia/reperfusion injury preparation
As described previously [11], after a minimum 
of 3-day recovery from intrathecal catheter place-
ment, animals were anesthetized by intraperitoneal 
pentobarbitone injection (80 mg/kg for control 
group 1 and RPCT group 1, 50 mg/kg for other 
groups). Anesthesia was maintained with repeat 
doses of 25 mg/kg intraperitoneal pentobarbitone 
every 60–90 min. Tracheotomy was performed 
and mechanical ventilation was commenced with 
a rodent respirator (Harvard Apparatus, Boston, 
MA, USA) using ambient air at a rate of 60– 
–70 breaths/min. Body temperature was maintained 
using a heating pad. For direct arterial blood pres-
sure monitoring, a heparinized (50 U/mL heparin 
saline) polyethylene catheter (external diameter, 
1.0 mm; internal diameter, 0.5 mm; Smiths Medical 
International) was inserted into the right carotid 
artery and connected to a pressure transducer. The 
catheter was flushed with 0.5 mL heparin saline 
(50 U/mL) every 30 min via a three-way tube. Lead II 
of the electrocardiogram was monitored using sub-
cutaneous stainless-steel electrodes connected to 
a monitoring system (ML750 PowerLab/4SP with 
ML T0380 reusable blood pressure transducer; AD 
Instruments, Colorado Springs, CO, USA). For saline 
infusion, a polyethylene catheter was inserted into 
the right jugular vein. The heart was exposed at the 
fifth intercostal space after left thoracotomy was per-
formed. After removing the pericardium, a 6-0 suture 
(Jinhuan medical company, Shanghai, China) loop and 
snare occluder was placed at the origin of the left 
main coronary artery. Regional myocardial ischemia 
was performed by pulling the snare and securing 
the threads with a mosquito hemostat. Ischemia was 
confirmed by the appearance of myocardial cyanosis 
in the distribution of the left coronary artery, a de-
crease in mean arterial blood pressure (MAP), and 
electrocardiographic ST segment changes. Data from 
24 rats in which severe hypotension (MAP < 30 mm 
Hg) or intractable ventricular fibrillation occurred 
were excluded from the study.
Remote preconditioning of trauma
An abdominal incision was used as the non-is-
chemic stimulus for RPCT, as described previously 
[2]. The incision (length, 2 cm) was made along the 
abdominal midline through the skin, subcutaneous 
tissue, fat, muscle, and peritoneum. It was closed 
immediately using 7-0 polypropylene sutures (Jin-
huan medical company, Shanghai, China).
Hemodynamics record
As shown in Figure 1, hemodynamic values, 
including heart rate (HR), MAP, and rate pressure 
product (RPP), were collected at the timepoints 
of baseline, treatment, ischemia and reperfusion.
Determination of myocardial infarct  
size and plasma concentration  
of cardiac troponin I
After completion of the reperfusion period, 
hearts of 6 animals in each group were excised and 
transferred to a Langendorff apparatus, perfused 
with normal saline for 1 min at a pressure of 100 cm 
H2O to flush out residual blood. The snare was 
securely re-tightened and 0.25% Evans Blue dye 
was injected to stain the normally perfused region. 
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This procedure allowed visualizing the normal, 
non-ischemic region and the area at risk. The 
heart was then frozen and cut into 2-mm slices. 
Thereafter, the slices were stained by incubation 
at 37°C for 20 min in 1% 2,3,5-triphenyltetrazolium 
(Sigma Aldrich, St. Louis, USA) in a phosphate 
buffer at pH 7.4. This was followed by immersion 
in 10% formalin for 20 min to enhance contrast 
of the stain. The infarct size (IS) was quantified 
as a percentage of the area at risk (AAR) using 
a previously described computerized planimetric 
technique (SigmaScan 4.0; Systat Software Inc, 
Richmond, CA, USA) [11]. Arterial blood samples of 
these 6 animals (5 mL) were obtained at the end of 
reperfusion and centrifuged at 3,000 rpm for 10 min 
to obtain plasma. The plasma cardiac troponin I 
(cTnI) concentration was determined as previously 
described [12], using a commercially available as-
say kit (R&D Systems, Minneapolis, USA).
Determination of myocardial intercellular 
adhesion molecule 1 concentration
Immediately after reperfusion, the hearts of 
another 6 animals (not including control group 1 
and RPCT group 1) were removed. Myocardial 
tissue in the approximate area supplied by the left 
coronary artery was excised and frozen using liquid 
nitrogen. The intercellular adhesion molecule 1 
(ICAM-1) concentration was determined as de-
scribed previously [13], using a commercially avail-
able assay kit (R&D Systems, Minneapolis, USA).
Examination of protein kinase C epsilon  
activation in myocardial cell membranes
The remaining 6 animals (not including control 
group 1 and RPCT group 1) were used for PKCe 
activation analysis and adenosine release detection 
(see below). For analysis of PKCe activation in 
myocardial cell membranes, the heart was excised 
and left ventricular (tissue from the area at risk) 
samples were collected 5 min after the onset of 
reperfusion. These tissues were frozen using liq-
uid nitrogen immediately before storage at –80°C. 
Frozen tissues were powdered and homogenized 
in buffer A (5 mM Tris, 4 mM ethylene glycol 
tetraacetic acid, 2 mM ethylenediaminetetraacetic 
acid [EDTA], 5 mM dithothreitol, 1 mM phenyl-
methyl sulfonyl fluoride, and EDTA-free protease 
inhibitor [1 tablet/10 mL]). The homogenate was 
centrifuged at 100,000 g at 4°C for 30 min to discard 
the supernatant. The pellet was collected and re-
homogenized with buffer A, containing 1% Triton X, 
by incubation on ice for 20 min, then centrifuged 
at 100,000 g at 4°C for 30 min. The supernatant 
was considered a membrane-associated fraction. 
Protein concentration was determined by assay 
(Bio-Rad, Hercules, CA, USA). PKCe was detected 
as described previously [2], by sodium dodecyl 
sulfate–polyacrylamide gel electrophoresis using 
an antibody obtained from Cell Signaling Technol-
ogy (Boston, MA, USA). Equal protein loading was 
confirmed using glyceraldehyde-3-phosphate dehy-
drogenase. Relative densitometry was performed 
using the Quantity One software package (Bio-Rad).
Detection of adenosine release  
in the spinal cord
For the analysis of adenosine release, spinal 
cord tissue from the T1–T5 region was collected 
5 min after the onset of reperfusion. Tissue sam-
ples were homogenized in ice-cold perchloric acid 
(6%) and centrifuged at 16,000 g at 9°C for 5 min. 
The supernatant was removed and neutralized with 
1.65 mol/L potassium carbonate, then centrifuged 
as described above, and the supernatant was re-
moved and then frozen in liquid nitrogen.
Adenosine levels in tissue extracts were de-
termined by high-performance liquid chromatog-
raphy (HPLC) coupled with ultraviolet detection, 
using a method modified from Hagberg et al. [14] 
Samples (20 μL) were passed through a 0.45-μm 
filter, injected via an autosampler (717Plus; Waters, 
Milford, MA, USA), and eluted (1 mL/min) using 
50/4 mmol/L NaH2PO4/Na2HPO4 (pH 5.8 at room 
temperature). Separation was achieved with a C18 
column (Waters), while temperature was main-
tained at 35°C with a column heater compartment. 
Peaks were detected at 260 nm using a Waters 2487 
dual-channel absorbance detector, and results were 
quantified by comparing peak areas with known 
standards using Breeze 3.30 software (Waters). 
Adenosine peaks were identified by comparison 
of retention times and with standard substances 
with known adenosine quantities (Sigma Aldrich, 
St. Louis, USA).
Statistical analysis
Data were expressed as mean ± standard 
deviation and analyzed using the Prism software 
package (version 4.0; GraphPad Software, San 
Diego, CA, USA). Hemodynamic data were exam-
ined using two-way analysis of variance with Bon-
ferroni correction for multiple comparisons when 
significant F ratios were obtained. IS/AAR was 
compared among groups using analysis of variance 
with the post-hoc Student–Newman–Keuls test for 
multiple comparisons. Statistical differences were 
considered significant when p values were < 0.05.
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Results
Hemodynamics
Compared with baseline values, HR, MAP, and 
RPP decreased significantly after 30 min ischemia 
and 120 min reperfusion in all groups except the 
sham group (p < 0.05; Table 1). These values were 
significantly lower in all groups apart from the sham 
group at these timepoints (p < 0.05).
Myocardial infarct size and cardiac  
troponin I concentration
Compared with the sham group, IR injury mark-
edly increased the cTnI concentration (p < 0.001; 
Table 2). IPC significantly reduced the IS/AAR 
(p < 0.001; Table 2; Fig 2) and the cTnI concentra-
tion compared with control group 2 (p < 0.001). 
Similarly, compared with control groups, RPCT 
not only reduced the IS/AAR (p < 0.01) and the 
cTnI concentration (p < 0.01) when rats were an-
esthetized with 80 mg/kg pentobarbitone, but also 
reduced the IS/AAR (p < 0.001) and the cTnI con-
centration (p< 0.01) when rats were anesthetized 
using 50 mg/kg pentobarbitone. CTOP eliminated 
the effect of RPCT on IS/AAR (p < 0.001) and the 
concentration of cTnI (p < 0.05), but no differences 
between the RPCT group 2 and the NTD + RPCT 
or nor-BNI + RPCT group were observed. In addi-
tion, no difference was observed between control 
group 2 and the three opioid receptor antagonist 
self-control groups.
Myocardial intercellular adhesion  
molecule 1 expression
Compared with the sham group, IR injury 
markedly increased ICAM-1 expression (p < 0.001; 
Table 2). IPC significantly reduced ICAM-1 expres-
sion compared with control group 2 (p < 0.001). 
Similarly, ICAM-1 expression was lower in RPCT 
group 2 than in control group 2 (p < 0.001). This 
expression was significantly higher in the CTOP + 
+ RPCT group than in the RPCT group (p < 0.001), 
but no differences between RPCT group 2 and the 
NTD + RPCT or nor-BNI + RPCT group were ob-
served. In addition, no differences were observed 
between the control group 2 and the three opioid 
receptor antagonist self-control groups.
Protein kinase C epsilon activation  
in myocardial cell membrane
Ischemia/reperfusion injury increased PKCe 
activation in the myocardial cell membrane com-
pared with the sham group (p < 0.05; Fig 3). Com-
pared with control group 2, PKCe activation was 
further enhanced in the IPC group and RPCT group 
2 (both p < 0.01). Among opioid receptor antago-
nists, only CTOP eliminated the effect observed 
in RPCT group 2 (p < 0.05). No differences were 
observed between control group 2 and the three 
opioid receptor antagonist self-control groups.
Adenosine release in spinal cord
An adenosine peak was detected via HPLC at 
nearly 10 min after onset of detection (Fig. 4). IR 
injury increased the release of adenosine in the 
spinal cord, but this difference was not significant. 
Adenosine release observed in the IPC group and 
RPCT group 2 was greater than in control group 
2 (both p < 0.05; Fig. 5). Among opioid receptor 
antagonists, only CTOP eliminated the enhance-
ment observed in RPCT group 2 (p < 0.05). No 
differences were observed between the control 
group 2 and the three opioid receptor antagonist 
self-control groups.
Discussion
The present data suggest that RPCT had 
a cardioprotective effect against IR injury by means 
of activation of  mu-opioid receptors in the spinal 
cord in the rat model. Enhancement of adenosine 
release in the central nervous system mediated the 
cardioprotective effect of RPCT. In the peripheral 
nervous system, PKCe activation and inhibition of 
inflammation also contributed to this mechanism.
Remote preconditioning of trauma is a non-
ischemic cardioprotective method, first reported 
in 2004 [1], and confirmed by animal studies in 
mouse and rat myocardial ischemia reperfusion 
models [15, 16]. However, in previous studies, 
depth of anesthesia seemed insufficient, which 
weakened the clinical value of these studies [17]. 
In the current study, we used the IPC group as the 
positive control and anesthetized animals using two 
different dosages of pentobarbitone. We found that 
RPCT reduced the size of infarcts and elevated 
cTnI concentration induced by IR injury, which is 
irrelevant to anesthesia depth.
In our previous study, we found that intrathecal 
administration of the non-selective opioid receptor 
antagonist naloxone before RPCT eliminated the 
cardioprotective effect conferred by RPCT [3]. To 
further identify the involvment of opioid receptor 
subtypes in this mediation, we tested three opioid 
receptor antagonists (NTD, nor-BNI, and CTOP) 
in the present study. Among opioid receptors in the 
spinal cord, only the mu receptors mediated the 
protective effect of RPCT. This result differed from 
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Li’s finding, which indicated that all three opioid 
receptor subtypes mediated the protective effect 
of intrathecal morphine preconditioning [6]. This 
difference can be explained by the potential mecha-
nism of RPCT and the roles of spinal cord opioid 
receptor subtypes in the modulation of nociceptive 
stimulation. The greatest difference between the 
present study and our previous research is that 
Table 1. Hemodynamics for all groups at baseline treatment, 30 min of ischemia and 120 min of reperfusion.
Baseline Treatment 30 min ischemia 120 min reperfusion
Heart rate [bpm]
Sham 385 ± 43 378 ± 33 374 ± 39 365 ± 38
Control 1 372 ± 57 361 ± 46 331 ± 44*# 325 ± 59*#
Control 2 389 ± 43 376 ± 34 343 ± 39*# 342 ± 37*#
IPC 386 ± 32 351 ± 21 337 ± 33*# 331 ± 29*#
RPCT 1 375 ± 52 369 ± 43 343 ± 52*# 336 ± 61*#
RPCT 2 381 ± 38 377 ± 28 356 ± 35*# 348 ± 37*#
CTOP+RPCT 396 ± 37 382 ± 27 334 ± 35*# 344 ± 33*#
nor-BNI+RPCT 379 ± 36 376 ± 33 340 ± 35*# 330 ± 32*#
NTD+RPCT 387 ± 39 379 ± 22 340 ± 37*# 337 ± 34*#
CTOP+I/R 391 ± 37 377 ± 26 347 ± 37*# 342 ± 32*#
nor-BNI+I/R 382 ± 39 376 ± 29 352 ± 35*# 348 ± 35*#
NTD+I/R 395 ± 28 381 ± 19 351 ± 28*# 345 ± 23*#
Mean arterial pressure [mm Hg]
Sham 99 ± 15 91 ± 10 88 ± 13 88 ± 12
Control 1 100 ± 19 92 ± 11 76 ± 13*# 79 ± 16*#
Control 2 98 ± 13 89 ± 14 74 ± 11*# 82 ± 11*#
IPC 98 ± 12 87 ± 9 71 ± 8*# 79 ± 13*#
RPCT 1 95 ± 15 92 ± 14 69 ± 12*# 71 ± 11*#
RPCT 2 97 ± 13 91 ± 11 75 ± 8*# 78 ± 12*#
CTOP+RPCT 93 ± 13 89 ± 12 72 ± 10*# 80 ± 10*#
nor-BNI+RPCT 97 ± 9 92 ± 9 74 ± 9*# 82 ± 9*#
NTD+RPCT 91 ± 12 89 ± 13 70 ± 9*# 80 ± 9*#
CTOP+I/R 93 ± 11 88 ± 11 69 ± 10*# 79 ± 10*#
nor-BNI+I/R 94 ± 13 90 ± 12 71 ± 9*# 79 ± 9*#
NTD+I/R 94 ± 11 89 ± 11 71 ± 11*# 81 ± 11*#
Rate pressure product [mm Hg/min/1000]
Sham 39 ± 10 35 ± 6 33 ± 8 32 ± 8
Control 1 37 ± 10 35 ± 5 25 ± 7*# 26 ± 4*#
Control 2 39 ± 9 34 ± 8 26 ± 6*# 28 ± 7*#
IPC 38 ± 8 31 ± 4 23 ± 5*# 26 ± 6*#
RPCT 1 36 ± 9 34 ± 6 25 ± 8*# 24 ± 8*#
RPCT 2 37 ± 9 35 ± 7 27 ± 6*# 28 ± 7*#
CTOP+RPCT 37 ± 9 34 ± 7 26 ± 6*# 28 ± 6*#
nor-BNI+RPCT 37 ± 7 34 ± 6 25 ± 5*# 27 ± 6*#
NTD+RPCT 36 ± 8 34 ± 7 24 ± 6*# 27 ± 5*#
CTOP+I/R 37 ± 8 34 ± 6 24 ± 6*# 27 ± 6*#
nor-BNI+I/R 36 ± 9 34 ± 7 25 ± 6*# 28 ± 6*#
NTD+I/R 37 ± 7 34 ± 6 25 ± 6*# 28 ± 6*#
*p < 0.05 vs. baseline; #p < 0.05 vs. sham group; abbreviations — see text
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endogenous opioid substances were investigated 
in the present study. RPCT can be considered a no-
ciceptive stimulation, which could enhance release 
of endogenous opioid substances in the spinal cord, 
thereby activating the opioid receptors. In the spi-
nal cord, among the three opioid receptor subtypes, 
the delta and mu receptors were reported to be the 
dominant modulators of excitatory substances [18]. 
Blockage of mu-opioid receptors in the spinal cord 
prevented the effects of subsequent systemic 
opioids [19]. With our findings in this study, we 
speculate that among the three opiod receptors in 
the spinal cord the mu-opioid receptors may be the 
dominant receptors involved in the cardioprotec-
tive effect of endogenous opioid substances in the 
spinal cord.
Table 2. Infarct size, plasma concentration of cardiac troponin I (cTnI) and expression of myocardial 
intercellular adhesion molecule 1 (ICAM-1).
Group LV+RV  
[cm3]








Sham 1.112 ± 0.135 0.593 ± 0.044 – – 0.42 ± 0.11 111 ± 9
Control 1 1.126 ± 0.142 0.599 ± 0.064 0.317 ± 0.041 0.529 ± 0.052 1.36 ± 0.07* –
Control 2 0.996 ± 0.109 0.619 ± 0.089 0.336 ± 0.039 0.543 ± 0.075 1.29 ± 0.09* 254 ± 17*
IPC 1.095 ± 0.097 0.601 ± 0.054 0.147 ± 0.026*** 0.245 ± 0.036*** 0.76 ± 0.13*** 132 ± 19***
RPCT 1 1.014 ± 0.079 0.617 ± 0.069 0.184 ± 0.039& 0.297 ± 0.072& 0.92 ± 0.15& –
RPCT 2 1.106 ± 0.068 0.591 ± 0.074 0.171 ± 0.024*** 0.289 ± 0.028*** 0.82 ± 0.11** 158 ± 21***
CTOP+RPCT 0.973 ± 0.109 0.599 ± 0.017 0.296 ± 0.047## 0.494 ± 0.04## 1.13 ± 0.16# 229 ± 24##
nor-BNI+RPCT 1.001 ± 0.072 0.576 ± 0.031 0.174 ± 0.034 0.302 ± 0.057 0.84 ± 0.2 151 ± 27
NTD+RPCT 1.061 ± 0.041 0.568 ± 0.029 0.203 ± 0.018 0.357 ± 0.016 0.81 ± 0.14 146 ± 16
CTOP+I/R 0.928 ± 0.162 0.564 ± 0.064 0.308 ± 0.059 0.546 ± 0.075 1.33 ± 0.17 273 ± 25
nor-BNI+I/R 0.986 ± 0.09 0.621 ± 0.052 0.312 ± 0.073 0.501 ± 0.046 1.26 ± 0.22 255 ± 12
NTD+I/R 1.203 ± 0.089 0.587 ± 0.027 0.293 ± 0.017 0.499 ± 0.048 1.17 ± 0.07 259 ± 16
LV+RV — the sum of left and right ventricles’ area; IS/AAR — infarct size expressed as a percentage of the area at risk; *p < 0.001 vs. sham 
group; &p < 0.01 vs. control group 1; **p < 0.01 vs. control group 2, ***p < 0.001 vs. control group 2; #p < 0.05 vs. RPCT group 2, ##p < 0.001 
vs. RPCT group 2; other abbreviations — see text
Figure 2. Pathology section of the myocardium after 2,3,5-triphenyltetrazolium chloride staining; A. Control group 1; 
B. RPCT group 1; C. Control group 2; D. IPC group; E. RPCT group 2; F. CTOP + RPCT group; G. Nor-BNI + RPCT 
group; H. NTD + RPCT group; I. CTOP group; J. Nor-BNI group; K. NTD group; abrreviations — see text.
320 www.cardiologyjournal.org
Cardiology Journal 2017, Vol. 24, No. 3
Several studies have proven the existence 
of “cross-talk” between the opioid and adenosine 
systems in the central nervous system. DeLander 
and Hopkins [20] demonstrated that adenosine 
receptors in the spinal cord may mediate the an-
tinociceptive effect of intracerebroventricular or 
intrathecal administration of morphine. Intrathecal 
morphine also enhanced adenosine release from 
the spinal cord, which conferred the antinociceptive 
effect [8, 21]. Activation of adenosine receptors in 
the spinal cord suppressed neutrophil adhesion in 
peripheral inflammatory locations via adenosine 
upregulation [9, 22]. Several studies have confrmed 
the effects of adenosine on nervous tissue, includ-
ing inhibition of the release of several classes of 
neurotransmitters, such as glutamate, through 
adenosine receptor activation [23, 24]. In the 
presence of inflammation, the hyperexcitability of 
Figure 3. Western blot analysis of protein kinase C epsilon (PKCe) in myocardial cell membrane. A. Representative 
quantitative immunoblots. B. PKCe band intensities were normalized to glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH). Values are presented as mean ± standard deviation. N = 6 in each group; △p < 0.05 vs. sham group; **p < 0.01 
vs. control group; #p < 0.05 vs. remote precoditioning of trauma (RPCT) group; other abbreviations — see text.
Figure 4. The chromatogram of adenosine. Adenosine peaks were identified by retention time comparisons and by 
standard substances with known quantities of adenosine. The adenosine peak in high-performance liquid chroma-
tography detection appeared nearly 10 min after start; A. Standard compounds; B. Extraction of rat spinal cord; 
mAU — milli absorbance unit.
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Figure 5. High-performance liquid chromatography 
analysis of adensoine release from the spinal cord. 
Values are present as mean ± standard deviation. 
N = 6 in each group; *p < 0.05 vs. control group; #p < 0.05 
vs. remote precoditioning of trauma (RPCT) group; oth-
er abbreviations — see text.
neurons increased, and glutamate conferred this 
effect [25, 26]. The concentration of glutamate in 
the spinal cord increased in the presence of periph-
eral inflammation [27]. Thus, reduced glutamate 
release may be one reason for the inhibitory effect 
of adenosine release in the spinal cord on periph-
eral neutrophil migration. In the present study, we 
found that both IPC and RPCT increased adeno-
sine release in the spinal cord and the mu-opioid 
receptor antagonist inhibited the effect of RPCT on 
adenosine release. Moreover, changes in myocar-
dial ICAM-1 concentrations were unaligned with 
changes in this adenosine release. These findings 
indicate that activation of mu-opioid receptors by 
means of RPCT increased adenosine release in the 
spinal cord, and this effect inhibited inflammation 
induced by IR injury.
Protein kinase C epsilon activation has been 
reported to mediate the cardioprotective effect of 
RPCT and suppress ICAM-1 expression induced 
by IR injury [28, 29]. To clarify the relationship of 
PKCe and ICAM-1 expression in the protective ef-
fect of RPCT, we investigated PKCe expression in 
myocardial cell membranes, as PKCe activation can 
be evaluated by examining its translocation from 
the cytoplasm to the membrane [2]. As expected, 
both IPC and RPCT increased PKCe activation, 
while CTOP inhibited the effect of RPCT. PKCe 
activation also reduced ICAM-1 expression in the 
myocardium.
Limitations of the study
There were some limitations in this study. We 
did not directly determine the activation of spinal 
opioid receptors during RPCT. However, as a no-
ciceptive stimulus, RPCT increased endogenous 
opioid release, thereby activating the mu recep-
tors. We did not directly test the spinal adenosine-
mediated effect with a selective adenosine receptor 
antagonist. In our previous study, activation of 
adenosine receptors had been confirmed as respon-
sible for mediating the cardioprotective effect of 
the spinal opioid system [30]. In the present study, 
we found that enhanced adenosine release was the 
reason for activation of adenosine receptors.
Conclusions
In conclusion, this study demonstrated that 
remote preconditioning of trauma protected the 
myocardium against IR injury in the rat heart, and 
spinal mu-opioid receptors mediated this effect. 
The potential mechanism may be enhanced by 
adenosine release in the spinal cord caused by ac-
tivation of mu-opioid receptors, which suppressed 
myocardial inflammation induced by IR injury. PKCe 
activation may also be involved in the mediating 
effect of central opioid receptors.
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